Clinical Trial Update: SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 SALT trial evaluating alternative donor bone marrow and cord blood transplantation for high-risk sickle cell disease. The study has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Emory University | Conditions: Sickle Cell Disease | EARLY_Phase 1 | Status: TERMINATED